Showing results (151-160 of 288) with videos related to

Sort By:
Pageof 29
Scientific Reports|June 25, 2020
Role of gene signatures combined with pathology in classification of oropharynx head and neck cancerAndrew Dhawan, Jacob Scott, Purnima Sundaresan, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 16, 2015
¹⁸F-FDG PET/CT following chemoradiation of uterine cervix cancer provides powerful prognostic stratification independent of HPV status: a prospective cohort of 105 women with mature survival dataShankar Siva, Siddhartha Deb, Richard J Young, et al.
The Australasian Journal of Dermatology|November 9, 2021
Cutaneous squamous cell carcinoma metastatic to the axilla and groin: Outcomes and prognostic factorsNicholas W Bucknell, David E Gyorki, Mathias Bressel, et al.
NPJ Precision Oncology|March 20, 2021
Complete response to PD-1 blockade following EBV-specific T-cell therapy in metastatic nasopharyngeal carcinomaCorey Smith, Margaret McGrath, Michelle A Neller, et al.
International Journal of Radiation Oncology, Biology, Physics|September 24, 2004
Early FDG-PET imaging after radical radiotherapy for non-small-cell lung cancer: inflammatory changes in normal tissues correlate with tumor response and do not confound therapeutic response evaluationRodney J Hicks, Michael P Mac Manus, Jane P Matthews, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2010
Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: results from TROG 02.02Lester J Peters, Brian O'Sullivan, Jordi Giralt, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|March 30, 2017
Rotational forceps versus manual rotation and direct forceps: A retrospective cohort studyStephen O'Brien, Fiona Day, Erik Lenguerrand, et al.
Leukemia & Lymphoma|April 11, 2014
Pneumocystis jirovecii pneumonia associated with gemcitabine chemotherapy: experience at an Australian center and recommendations for targeted prophylaxisSenthil M Lingaratnam, Monica A Slavin, Karin A Thursky, et al.
Journal of the American Academy of Dermatology|November 30, 2025
Extended follow-up outcomes of patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab on EMPOWER-CSCC-1: A retrospective cohort studyCatherine Bennett, Luke S McLean, Annette M Lim, et al.
The Cochrane Database of Systematic Reviews|April 22, 2025
Delivery of intravenous anti-cancer therapy at home versus in hospital or community settings for adults with cancerLiesl Grobler, Denise O'Connor, Danny Rischin, et al.
Pageof 29